CMS amends CY 2023 fee guidance for independent dispute resolution process; Agencies issue initial report for April-September

Dec 27, 2022 - 01:30 PM
cms-nh-work-for-medicaid

The Center for Medicare & Medicaid Services has amended its 2023 fee guidance for the federal independent dispute resolution process, the agency announced last week. Under the amended guidance, administrative fees due from each party for participating in independent dispute resolutions will increase to $350 per party. Additionally, CMS says updated entity fees, which take effect Jan. 1, 2023, can be found here.

Additionally, the departments of Health and Human Services, Labor and Treasury issued their initial report on the federal independent dispute resolution process. The report, which covers the period of April 15 through Sept. 22, includes information on the number of disputes initiated; the number of disputes closed; the types of parties engaged in disputes; the types of services under dispute; and the states in which disputed items and services were provided.

Related News Articles

Headline
KFF: Medicare spent 27% more for people who disenrolled from MA than those continuously in Traditional Medicare
An analysis by KFF released last week found that in 2022, Medicare spent 27% ($2,585) more, on average, for individuals covered by Traditional Medicare after…
Headline
Bipartisan letter calling for prevention of Medicaid DSH cuts gets signatures from 182 members of Congress
A House Dear Colleague letter calling on House leadership to address scheduled Medicaid Disproportionate Share Hospital payment cuts received signatures from…
Headline
AHA responds to Medicare $2 Drug List Model request for information
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Headline
AHA supports physician reimbursement, alternative payment model incentives in comments to MedPAC
In comments Dec. 9 to the Medicare Payment Advisory Commission, the AHA shared its views on physician fee schedule payments, advanced alternative payment model…
Headline
CMS announces two drug manufacturers to participate in CGT Access Model 
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
CMS releases proposed rule for 2026 Medicare Advantage, prescription drug plans
The Centers for Medicare & Medicaid Services Nov. 26 proposed changes to the Medicare Advantage and prescription drug programs for contract year 2026.…